1-3 of 3
Georg Gelbenegger
Close
Sort by
Journal Articles

Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease

Clinical Trials & Observations
Georg Gelbenegger, Ulrich Jäger, Michael Fillitz, Christian Schörgenhofer, Christian Sillaber, Bernd Jilma
Journal: Blood Advances
Blood Adv (2023) 7 (10): 1987–1990.
https://doi.org/10.1182/bloodadvances.2022008574
Published: 2023
Includes: Supplemental data
Journal Articles

The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease

Clinical Trials & Observations
Cihan Ay, Ingrid Pabinger, Katarina D. Kovacevic, Georg Gelbenegger, Christian Schörgenhofer, Peter Quehenberger, Petra Jilma-Stohlawetz, Raute Sunder-Plassman, James C. Gilbert, Shuhao Zhu, Bernd Jilma, Ulla Derhaschnig
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5467–5476.
https://doi.org/10.1182/bloodadvances.2022007805
Published: 2022
Includes: Supplemental data
Journal Articles

Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program

Clinical Trials & Observations
Georg Gelbenegger, Christian Schoergenhofer, Ulla Derhaschnig, Nina Buchtele, Christian Sillaber, Michael Fillitz, Thomas M. Schenk, Shirley D’Sa, Ronwyn Cartwright, James C. Gilbert, Bernd Jilma, Ulrich Jaeger
Journal: Blood Advances
Blood Adv (2020) 4 (6): 997–1005.
https://doi.org/10.1182/bloodadvances.2019001321
Published: 2020
Includes: Supplemental data